Force sensing resistor for liquid low-volume detection and occlusion sensing and methods and apparatuses for flow sensing along fluid path in fluid delivery device
US-2017258993-A1 · Sep 14, 2017 · US
US10905356B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10905356-B2 |
| Application number | US-201515507386-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 28, 2015 |
| Priority date | Aug 28, 2014 |
| Publication date | Feb 2, 2021 |
| Grant date | Feb 2, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compliance monitoring module for an inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being configured to be pneumatically coupled to a flow channel of said inhaler through which a user can inhale; a processor configured to: receive data from a sensing element of the pressure sensor; receive data from a mode sensor configured to detect when the inhaler changes from an inactive mode to an active mode; and based on said data from said pressure sensor sensing element and said data from said mode sensor, compile a compliance report; and a transmitter configured to issue said compliance report.
Opening claim text (preview).
The invention claimed is: 1. A pressurized metered dose inhaler (pMDI) comprising: a boot-shaped housing; a medication canister comprising medicament received within the boot-shaped housing; a top cover attached to an upper section of the boot-shaped housing and that conceals a top side of the medication canister; and a monitoring module located between an underside of the top cover and a top of the medication canister, the monitoring module comprising: a microelectromechanical system (MEMS) or a nanoelectromechanical system (NEMS) pressure sensor comprising a sensor port, wherein the sensor port is configured to be pneumatically coupled to a flow channel of the pMDI through which a user can inhale; a processor configured to receive data from a sensing element of the MEMS or NEMS pressure sensor; and a wireless transmitter configured to transmit the data to a user device; and wherein the MEMS or NEMS pressure sensor, the processor, and the wireless transmitter are located entirely in-between the underside of the top cover and the top of the medication canister. 2. The pMDI of claim 1 , wherein the monitoring module further comprises an orientation sensor, and wherein the processor is further configured to determine that the pMDI has been primed for use based on feedback from the orientation sensor. 3. The pMDI of claim 1 , wherein the MEMS or NEMS pressure sensor is a MEMS or NEMS barometric pressure sensor. 4. The pMDI of claim 3 , wherein the processor is configured to record a tare pressure reading prior to receiving the data from the sensing element. 5. The pMDI of claim 1 , wherein the monitoring module further comprises a temperature sensor, and wherein the processor is configured to receive data from the temperature sensor and the wireless transmitter is configured to transmit the data from the temperature sensor to the user device. 6. The pMDI of claim 1 , wherein the monitoring module is affixed to the underside of the top cover. 7. The pMDI of claim 1 , wherein the data comprising a flow profile of a user of the pMDI. 8. The pMDI of claim 1 , wherein the data indicates whether the user of the pMDI inhaled in a manner sufficient to receive a full dose of medicament. 9. The pMDI of claim 1 , wherein the data comprises an indication of an actuation of the pMDI and sensed inhalation data with associated time stamps. 10. The pMDI of claim 1 , further comprising a light emitting diode (LED), wherein the processor is configured to generate an alert using the LED to indicate a user's non-compliance with a dosing regimen of the pMDI or to provide a dose reminder to the user of the pMDI. 11. The pMDI of claim 1 , wherein the medication canister comprises beclomethasone dipropionate. 12. The pMDI of claim 1 , wherein the monitoring module further comprises an electronic switch that is configured to be actuated when a dose of medicament is metered from the pMDI. 13. The pMDI of claim 1 , wherein the monitoring module further comprises a switch that is configured to wake the MEMS or NEMS pressure sensor from a low power state, wherein the MEMS or NEMS pressure sensor is configured to take a tare reading after waking from the low power state. 14. A system comprising: a user device comprising a processor; and a pressurized metered dose inhaler (pMDI) comprising: a boot-shaped housing; a medication canister comprising medicament received within the boot-shaped housing; a top cover attached to an upper section of the boot-shaped housing and that conceals a top side of the medication canister; and a monitoring module located entirely in a space between an underside of the top cover and a top of the medication canister, the monitoring module comprising: a microelectromechanical system (MEMS) or a nanoelectromechanical system (NEMS) pressure sensor comprising a sensor port, wherein the sensor port is configured to be pneumatically coupled to a flow channel of the pMDI through which a user can inhale; a processor configured to receive data from a sensing element of the MEMS or NEMS pressure sensor; and a wireless transmitter configured to transmit the data to a user device; and wherein the processor of the user device is configured to process the data from the sensing element and determine, based on the data, whether one or more predetermined requirements for successful dosing are met. 15. The system of claim 14 , wherein the medication canister comprises beclomethasone dipropionate. 16. The system of claim 14 , wherein the processor of the user device is configured to determine, based on the data, that successful dosing is met when an inhalation duration exceeds a predetermined threshold value. 17. The system of claim 14 , wherein the processor of the user device is configured to determine, based on the data, that successful dosing is met when a flow rate exceeds a predetermined threshold value for at least a predetermined threshold duration. 18. The system of claim 14 , wherein the processor of the user device is configured to determine, based on the data, that successful dosing is met when a total volume inhaled exceeds a predetermined threshold value. 19. The system of claim 14 , wherein the processor of the user device is configured to determine, based on the data, that successful dosing is met when a peak inspired flow (PIF) exceeds a predetermined threshold value. 20. The system of claim 14 , wherein the data comprising a flow profile that indicates fluctuations of pressure detected by the MEMS or NEMS pressure sensor; and wherein the processor of the user device is configured to determine an inhalation duration or inhalation volume based on the flow profile.
relating to drugs or medications, e.g. for ensuring correct administration to patients · CPC title
on the body · CPC title
battery-operated · CPC title
with microprocessors or computers · CPC title
pressure meter · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.